Perrigo Asthma Inhalers Recalled Due to Clog Risk

WEDNESDAY, Sept. 23, 2020 (HealthDay News) -- Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.

The retail recall is for all unexpired albuterol sulfate inhalation aerosol made by Catalent Pharma Solutions for Perrigo Pharmaceutical Company. The inhalers are used to treat asthma and other airway/lung conditions, such as chronic obstructive pulmonary disease.

Patients should continue to use the Perrigo inhaler they have, as needed and as directed by a doctor, the FDA said.

Some of the recalled inhalers stop working after several uses. If their rescue albuterol inhaler malfunctions and doesn't relieve symptoms in an emergency situation, patients should immediately seek emergency care if needed, the FDA advised.

It recommended that patients have extra inhalers or an alternative treatment available in case of inhaler malfunction.

For more information, patients should talk with their health care provider or pharmacist, the FDA said.

Copyright © 2019 HealthDay. All rights reserved.


Asthma is a chronic respiratory disease. See Answer

Health Solutions From Our Sponsors